{
    "clinical_study": {
        "@rank": "83974", 
        "arm_group": [
            {
                "arm_group_label": "Ultrasound plus prosodic cues", 
                "arm_group_type": "Experimental", 
                "description": "One sound in error is treated with ultrasound visual feedback while also cueing prosodic variation (7 one-hour sessions). Another sound in error is treated with the ultrasound visual feedback with no prosodic variation (7 one-hour sessions). Prosodic variations are cues to coordinate production of the target sound with intonation patterns such as questions (rising intonations), commands (loud/emphatic), or statements (neutral)"
            }, 
            {
                "arm_group_label": "Ultrasound vs Traditional treatment", 
                "arm_group_type": "Experimental", 
                "description": "One sound in errors is treated with ultrasound visual feedback for approximately half of each session and traditional treatment for half of the session (7 one-hour sessions). Another sound in error is treated with no ultrasound visual feedback, using traditional treatment for the entire session (7 one-hour sessions). These traditional cues include verbal instructions on how to move the tongue to achieve a particular speech sound."
            }
        ], 
        "brief_summary": {
            "textblock": "Children with speech sound disorders will receive speech therapy using real-time images of\n      the tongue from ultrasound. These images will be used to cue the child to change the tongue\n      position when producing speech sounds."
        }, 
        "brief_title": "Ultrasound Biofeedback for Speech Sound Disorders", 
        "condition": "Speech Sound Disorders", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Participants must be native English-speaking children with no known hearing or vision\n             deficits. Participants must be within the specified age range  and have been\n             identified as having speech production difficulties by a local speech-language\n             therapist.\n\n        Exclusion Criteria:\n\n          -  Participants will be excluded if there is a history of oral structural impairment\n             (e.g., cleft palate), hearing or vision impairment, history of neurological\n             impairment or injury, developmental disabilities such as Down Syndrome or Autism, or\n             intellectual disability.\n\n        During initial testing, participants must score below a standard score of 75 on the\n        Goldman-Fristoe Test of Articulation-2 and also score below 20% accurate on a probe list\n        of words assessing accuracy of the /r/ sound"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "8 Years"
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01905449", 
            "org_study_id": "HaskinsA185"
        }, 
        "intervention": {
            "arm_group_label": [
                "Ultrasound plus prosodic cues", 
                "Ultrasound vs Traditional treatment"
            ], 
            "description": "Real-time visual displays of the tongue are used to cue participants to modify the tongue position/shape as they articulate speech sounds", 
            "intervention_name": "Ultrasound visual feedback", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 18, 2013", 
        "link": {
            "url": "http://www.haskins.yale.edu/inner_content/studies.html"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "New Haven", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06511"
                }, 
                "name": "Haskins Laboratories"
            }, 
            "investigator": {
                "last_name": "Jonathan Preston", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Biofeedback and Speech Disorders", 
        "overall_contact": {
            "email": "whittle@haskins.yale.edu", 
            "last_name": "Jessica Whittle, MA/CCC-SLP", 
            "phone": "203-865-6163", 
            "phone_ext": "245"
        }, 
        "overall_contact_backup": {
            "email": "preston@haskins.yale.edu", 
            "last_name": "Jonathan Preston, PhD/CCC-SLP", 
            "phone": "203-865-6163", 
            "phone_ext": "247"
        }, 
        "overall_official": {
            "affiliation": "Haskins Laboratories", 
            "last_name": "Jonathan Preston, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Percent correct for target speech sound", 
            "safety_issue": "No", 
            "time_frame": "Change in accuracy after 7 one-hour treatment sessions (3.5 weeks), and after 14 one-hour treatment sessions (7 weeks)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01905449"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Yale University", 
            "investigator_full_name": "JPreston", 
            "investigator_title": "Research Scientist, Haskins Laboratories", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Yale University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yale University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}